 Home > Popular Keywords > Keyword List G > gb biosciences

gb biosciences

You want to know gb biosciences information? Echemi helps you to follow gb biosciences top topics, hotspots and trends.

Twist Bioscience Joins Global Network Storage Industry Association as a Voting Member

 Time of Update: 2022-05-16

We believe DNA provides a long-term data storage medium to be considered under this Charter and welcome Twist Bioscience as a voting member of SNIA .
Junshi Biosciences completes the first patient dosing in the JUPITER-15 study of toripalimab

 Time of Update: 2022-05-03

for gastric or esophagogastric junction adenocarcinoma after radical resection. The Phase III clinical study of adjuvant therapy (hereinafter referred to as "JUPITER-15 study", NCT05180734) has completed the first patient dosing
The results of Phase II clinical trial of VVN001, an innovative drug for dry eye disease of Vimbi Biosciences in the United States, are positive

 Time of Update: 2022-04-23

VivaVision, a clinical-stage biotechnology company focusing on ophthalmology, is pleased to announce that its self-developed innovative drug VVN001 has achieved positive results in the US Phase II clinical trial for dry eye disease .
GB 30871-2022 "Safety Specifications for Special Operations of Hazardous Chemical Enterprises" was released and implemented on October 1

 Time of Update: 2022-04-15

Operation Safety Specification for Hazardous Chemical Enterprises" (GB 30871-2022) . As a national mandatory standard, the new specification will be officially implemented on October 1, 2022
Junshi Biosciences Announces Latest Data on Urothelial Carcinoma of PD-1 Inhibitor

 Time of Update: 2022-03-05

At this ASCO-GU conference, the POLARIS-03 study once again updated the 2-year survival data and biomarker analysis results of toripalimab in patients with advanced urothelial carcinoma who had failed previous systemic therapy.
C2i Genomics partners with Twist Bioscience to launch reference material for genome-wide cancer detection

 Time of Update: 2022-03-03

Cancer intelligence company C2i Genomics and Twist Bioscience recently announced a collaboration to develop genome-wide cancer reference materials .
Twist Bioscience launches 96-plex library preparation kit for low-depth, high-throughput next-generation sequencing

 Time of Update: 2022-01-25

Leproust, CEO and Co-Founder of Twist Bioscience, said: "The Twist 96-plex Library Prep Kit includes a robust PCR-like workflow for ultra-high-throughput library construction, allowing customers to utilize low-volume sequencing data to complete high-quality genotyping across the entire genome .
Abcam and Alamar Biosciences join hands to advance the understanding of the human proteome

 Time of Update: 2022-01-07

>These product combinations are designed to increase the probability of discovery of biomarkers and deepen the understanding of the circulating proteome. They have been specifically verified in advance and are suitable
Twist Bioscience reached a final agreement on the acquisition of Abveris, which will enhance biopharmaceutical capabilities

 Time of Update: 2022-01-04

Abveris is a privately-owned in vivo antibody discovery service company dedicated to the development of a new generation of biologics, cell therapies, vaccines and diagnostic products in cooperation with global biomedical leaders .
Twist Bioscience establishes a new company Revealar Biotherapeutics to develop and commercialize

 Time of Update: 2022-01-04

The new company will develop and commercialize an antibody discovered and optimized by Twist Biopharma (a division of Twist Bioscience) that neutralizes all known variants of the SARS-CoV-2 virus in preclinical studies .
Twist Bioscience launches circulating tumor DNA reference standard, suitable for the development of liquid biopsy analysis

 Time of Update: 2021-12-27

is composed of synthetically designed variant sequences and background DNA. The variant sequences mimic ctDNA, and the background DNA is derived from and highly mimics human cell-free DNA (cfDNA) .
Twist Bioscience is now selling a synthetic RNA positive control for the new crown mutant strain

 Time of Update: 2021-12-24

to help customers obtain A successful company, the company today announced the launch of a synthetic RNA positive control for the SARS-CoV-2 mutant strain Omi Keron (B. 1. 1. 529/BA. 1)
MRI-GB vs TRUS-GB: Who can locate prostate cancer lesions more accurately?

 Time of Update: 2021-12-05

in 2015 also pointed out that compared with TRUS-GB, MRI-GB has fewer side effects when detecting PCa, and the pain intensity suffered by patients is also lower [ 2] Therefore, we recommend MRI-GB as the first choice when locating prostate cancer
The new version of GB/T 18186 for approval no longer quotes GB 2717, what should companies do?

 Time of Update: 2021-12-03

? Does the implementation of GB 2717 ignore the amino acid nitrogen index? Today we will analyze together, if the new version of GB/T 18186 that is officially released in the future no longer references GB 2717, what
The pan-cancer methylation product jointly developed by Benchmark Medical and Twist Bioscience is launched globally

 Time of Update: 2021-11-05

This methylated pan-cancer detection product is a technical achievement jointly developed by Benchmark Medical and Twist in the past two years.
Twist Bioscience launches exome 2.0 for genomics research

 Time of Update: 2021-11-03

Twist Bioscience Corporation (Nasdaq: TWST (TWST) uses its silicon platform to provide high-quality synthetic DNA, today announced the launch of Exome 2.
National standard GB/T 39026-2020, identification of recycled polyester PET

 Time of Update: 2021-10-26

Based on the essential difference between the processing process of regenerated polyester and virgin polyester, which causes some characteristics to be different, the sample is processed according to the specified conditions and tested on a high performance liquid chromatograph.
Benchmark Medical/Twist Bioscience pan-cancer methylation products are launched globally

 Time of Update: 2021-10-21

from https:// The pan-cancer methylation product jointly developed by Benchmark Medical and Twist Bioscience is launched globally.
The pan-cancer methylation product jointly developed by Express Benchmark Medical and Twist Bioscience is launched globally

 Time of Update: 2021-10-21

"Reference material: [1] The pan-cancer methylation product jointly developed by Benchmark Medical and Twist Bioscience is launched globally.
Twist Bioscience and deep-learning deepCDR collaborate to design antibody library

 Time of Update: 2021-10-21

Twist is using its unique technology to manufacture a series of products based on synthetic DNA, including synthetic genes, next-generation sequencing (NGS) preparation tools, and antibody libraries for drug discovery and development .

Related Keywords

gaba a gb t 16483 is gaba a neurotransmitter gbs transmission m600 gb gb t 24001 gb jobs fb gb

Go to Page

Hot Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

good scents company(22)

glycation end products(70)

ghent wood products(43)

grace's market(57)

graco distributors(28)

What's trending

Top Keywords

grace general hospital careers

gas extinguisher

g46 4

g & w pharmaceuticals

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

gb biosciences

Related Tags

Related Keywords